COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF SPIRINOLACTONE AND EPLERENONE IN PATIENTS WITH DIFFERENT LEFT VENTRICULAR EJECTION FRACTION IN CHRONIC HEART FAILURE.
Yulduzxon BaxronovaCardiology department, Tashkent medial academy, Tashkent, UzbekistanMatluba RaximovaCardiology department, Tashkent medial academy, Tashkent, UzbekistanSagdiana BuranovaCardiology department, Tashkent medial academy, Tashkent, Uzbekistan
2023en
Ochiq kirishOlmos
Litsenziya: cc-by
ABI
Annotatsiya
In the article, the scientific literature confirming the effect of spirinolactone and eplerenone, belonging to the group of mineralocorticoid receptor antagonists, on the quality of life, the number of hospitalizations, the outcome of the disease, and the length of life of patients with chronic heart failure was studied, and the effects of these two drugs were comparatively evaluated.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos13 ta foydalanilgan manba